The titres of the neutralising antibodies – that specifically target the Sars-CoV-2 virus and kill it or prevent it from entering human cells – were also lower against the Delta variant as compared to the B1 variant that led to the first wave of infections in India.
Updated on Jul 04, 2021 03:30 AM IST
Covid recovered with even one dose of the vaccine have higher protection against Delta variant than those who have never been infected but have got vaccinated.
Published on Jul 03, 2021 10:51 PM IST
- The remarks by external affairs ministry spokesperson Arindam Bagchi came at a weekly news briefing on Friday.
Updated on Jul 02, 2021 09:20 PM IST
The Embassy of Switzerland has recently lifted travel restrictions and Indians fully vaccinated with Covishield can travel to Switzerland, but the country does not approve Covaxin.
Published on Jul 01, 2021 12:54 PM IST
Adar Poonwalla said Covishield will receive approval from the European Medicines Agency in a month.
Published on Jul 01, 2021 11:24 AM IST
Covid-19 vaccine shortage in India: Several states and Union territories, including Odisha, Punjab, and Delhi, have flagged a shortage of Covid-19 vaccines earlier this week amid the inoculation drive.
Published on Jul 01, 2021 06:23 AM IST
From July 1, a 'Green Pass' will be needed to travel freely within the European Union (EU). Covishield is not among the four vaccines cleared by the European Medicines Agency (EMA).
Updated on Jun 30, 2021 08:44 AM IST
By hindustantimes.com | Written by Karan Manral | Edited by Amit Chaturvedi, New Delhi
- The decision to cancel all vaccinations, including Covishield and Covaxin, has been taken due to "unavoidable" reasons, Chief Medical Officer Dr. Deepak Ohri said.
Published on Jun 29, 2021 10:35 PM IST
PTI | , Noida
- The official clarified that the EU Digital COVID Certificate is meant to facilitate restriction-free movement with the member states and is not a pre-condition to travel.
Updated on Jun 29, 2021 03:26 PM IST
The Serum Institute of India is approaching the European Medicines Agency for approval of its Covid-19 vaccine, Covishield, for the European Union’s Green Pass.
Published on Jun 29, 2021 05:28 AM IST
By hindustantimes.com | Written by Meenakshi Ray, New Delhi
Indian officials said it was “perplexing” that the list includes Vaxzevria, the AstraZeneca vaccine produced and marketed in the UK and other sites around Europe, but not Covishield, the version manufactured and distributed in India, though they are similar if not identical.
Updated on Jun 29, 2021 04:41 AM IST
Soni Razdan is unhappy about Covishield, a version of the AstraZeneca Covid-19 vaccine manufactured by Serum Institute of India and approved by WHO, being excluded from the eligibility list for the EU’s Green Pass.
Published on Jun 28, 2021 09:53 AM IST
The European Union had earlier said that member states can issue the certificates regardless of the type of Covid-19 vaccine, but the technical specifications indicate that the pass will be limited to “vaccines that have received EU-wide marketing authorization”.
Updated on Jun 28, 2021 05:48 AM IST
- Covishield, a version of the AstraZeneca Covid vaccine manufactured by Pune-based Serum Institute of India (SII), has not been approved by the EMA for the European market.
Published on Jun 27, 2021 07:53 PM IST
Serum Institute of India's (SII) Covishield, Bharat Biotech’s Covaxin and Russia’s Sputnik V are the three vaccines which have been cleared by the Indian government.
Published on Jun 27, 2021 10:49 AM IST
Written by Prashasti Singh | Edited by Meenakshi Ray, Hindustan Times, New Delhi
Daily recoveries continue to outnumber the single-day spike for the 43rd consecutive day, the central government said. The recovery rate has increased to 96.66% while the weekly positivity rate remains below 5% and is currently at 3%.
Published on Jun 25, 2021 10:01 AM IST
By hindustantimes.com | Edited by Joydeep Bose
- Mimi Chakraborty was invited to the vaccination camp on Wednesday by a man who claimed it was meant for inoculating transgender individuals and the disabled
Updated on Jun 24, 2021 08:18 PM IST
By hindustantimes.com | Edited by Ayshee Bhaduri, Hindustan Times, New Delhi
- “We are not vaccinating like Madhya Pradesh, inoculating lakhs in a day and unable to vaccinate even 1,000 on other days. We are not vaccinating for photo-ops or event management,” said Satyendar Jain
Updated on Jun 23, 2021 04:45 PM IST
By hindustantimes.com, Hindustan Times, New Delhi
- The aim of the government is to vaccinate all adults in the country against Covid-19 by the end of this year
Updated on Jun 21, 2021 01:06 AM IST
By Rhythma Kaul, New Delhi
- On Saturday, 85,907 people were vaccinated in Delhi, out of which 52,060 were from the 18-45 year age category.
Updated on Jun 21, 2021 05:08 AM IST
By HT Correspondent and PTI, New Delhi
- On June 16, Sunila Devi was administered shots of the two vaccines in a space of five minutes at the Utkramit Vidyalaya, a rural camp in Patna district’s Beldarichak village.
Published on Jun 20, 2021 03:53 AM IST
By Ruchir Kumar, Patna
- Presenting the Delhi government’s daily vaccination bulletin, the MLA from Kalkaji said Delhi now has 258,000 doses of Covishield and 37,000 doses of Covaxin available for the 18-44 age group.
Published on Jun 20, 2021 02:48 AM IST
By HT Correspondent, New Delhi
The goal of the immunisation policy in India, said Professor Andrew Pollard, is to ensure at least one dose of the Covid-19 vaccine for the largest number of people at the earliest, which is understandable with regards to the present coronavirus disease (Covid-19) situation in the country.
Published on Jun 19, 2021 07:19 AM IST
- The US embassy began scheduling visa interviews for Indian students this week and American officials have said applicants won’t require proof of Covid-19 vaccination to enter the US.
Updated on Jun 18, 2021 05:06 AM IST
- South Korea: Those who are vaccinated with Covaxin will have to follow quarantine guidelines for two weeks, unlike the ones who have received Covishield.
Published on Jun 16, 2021 10:38 PM IST
Experts who reportedly said the decision to increase the gap between the two doses of Covishield vaccines was not unanimous were present at the meeting and agreed to the decision, the government said on Wednesday and released proof.
Updated on Jun 16, 2021 06:49 PM IST
Rahul Gandhi, who has been the most vocal critic of the Centre’s response to the pandemic, has time and again criticised it over its vaccination policy. On May 28, he said vaccination is the only permanent solution to combat Covid-19 and only a minuscule percentage of the country’s population was inoculated.
Published on Jun 16, 2021 04:10 PM IST
By hindustantimes.com | Written by Harshit Sabarwal | Edited by Avik Roy, New Delhi
Covishield: Increasing the gap between the two doses of Covishield to 12 to 16 weeks was what all experts agreed to, the government has said after reports of dissent surfaces.
Published on Jun 16, 2021 09:51 AM IST
In the government’s vaccination bulletin issued online on Tuesday, Atishi said the position is “quite comfortable” for people aged 45 and above, and over 50% eligible people in this group have been vaccinated.
Updated on Jun 16, 2021 05:15 AM IST
- Announcing the decision to increase the gap between the two Covid-19 vaccine doses from six to eight weeks to 12-16 weeks, the government said it was recommended by NTAGI, based on real-life evidence mainly from the United Kingdom.
Published on Jun 15, 2021 10:47 PM IST